ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

AUTHOR GROUP

doi:https://doi.org/10.1093/annonc/mdv484

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

AUTHOR GROUP

Research output: Contribution to journal › Article › Academic › peer-review

821 Citations (Scopus)

Abstract

The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically relevant questions about endometrial cancer relating to the following four areas: prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article

Original language	English
Pages (from-to)	16-41
Journal	Annals of Oncology
Volume	27
Issue number	1
DOIs	https://doi.org/10.1093/annonc/mdv484
Publication status	Published - 2016

Access to Document

https://doi.org/10.1093/annonc/mdv484

Cite this

@article{b5a84960ccff4f2093b0f515593b90b5,

title = "ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up",

abstract = "The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically relevant questions about endometrial cancer relating to the following four areas: prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article",

author = "N. Colombo and C. Creutzberg and F. Amant and T. Bosse and A. Gonz{\'a}lez-Mart{\'i}n and J. Ledermann and C. Marth and R. Nout and D. Querleu and Mirza, {M. R.} and C. Sessa and {AUTHOR GROUP} and M. Abal and O. Altundag and {van Leeuwenhoek}, Antoni and S. Banerjee and A. Casado and {de Agust{\'i}n}, {L. C.} and D. Cibula and {del Campo}, J.-M. and G. Emons and F. Goffin and S. Greggi and C. Haie-Meder and D. Katsaros and V. Kesic and C. Kurzeder and S. Lax and F. L{\'e}curu and T. Levy and D. Lorusso and J. M{\"a}enp{\"a}{\"a} and X. Matias-Guiu and P. Morice and Nijman, {H. W.} and M. Powell and N. Reed and A. Rodolakis and H. Salvesen and J. Sehouli and A. Taylor and A. Westermann and Zeimet, {A. G.}",

year = "2016",

doi = "https://doi.org/10.1093/annonc/mdv484",

language = "English",

volume = "27",

pages = "16--41",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

AU - Colombo, N.

AU - Creutzberg, C.

AU - Amant, F.

AU - Bosse, T.

AU - González-Martín, A.

AU - Ledermann, J.

AU - Marth, C.

AU - Nout, R.

AU - Querleu, D.

AU - Mirza, M. R.

AU - Sessa, C.

AU - AUTHOR GROUP

AU - Abal, M.

AU - Altundag, O.

AU - van Leeuwenhoek, Antoni

AU - Banerjee, S.

AU - Casado, A.

AU - de Agustín, L. C.

AU - Cibula, D.

AU - del Campo, J.-M.

AU - Emons, G.

AU - Goffin, F.

AU - Greggi, S.

AU - Haie-Meder, C.

AU - Katsaros, D.

AU - Kesic, V.

AU - Kurzeder, C.

AU - Lax, S.

AU - Lécuru, F.

AU - Levy, T.

AU - Lorusso, D.

AU - Mäenpää, J.

AU - Matias-Guiu, X.

AU - Morice, P.

AU - Nijman, H. W.

AU - Powell, M.

AU - Reed, N.

AU - Rodolakis, A.

AU - Salvesen, H.

AU - Sehouli, J.

AU - Taylor, A.

AU - Westermann, A.

AU - Zeimet, A. G.

PY - 2016

Y1 - 2016

N2 - The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically relevant questions about endometrial cancer relating to the following four areas: prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article

AB - The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically relevant questions about endometrial cancer relating to the following four areas: prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article

U2 - https://doi.org/10.1093/annonc/mdv484

DO - https://doi.org/10.1093/annonc/mdv484

M3 - Article

C2 - 26634381

SN - 0923-7534

VL - 27

SP - 16

EP - 41

JO - Annals of Oncology

JF - Annals of Oncology

IS - 1

ER -